Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Apr 3, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2018 PForm 4 → | Apr 2, 4:05 pm EDT | Invitae CorpNVTA | Randal W ScottExecutive Chairman, Director | 44,444 | $4.50 | $199,998 | 3,550,669 | +1.27% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 3, 8:26 am EDT | CREDIT SUISSE ASSET MANAGEMENT INCOME FUND INCCIK | CSAM Americas Holding Corp.Other | 35,821 | $3.23 | $115,541 | 385,210 | +10.3% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 5:00 pm EDT | EVANS & SUTHERLAND COMPUTER CORPESCC | Peter R Kellogg10% Owner | 50,980 | $1.21 | $61,716 | 3,831,273 | +1.35% | plan? |
| Feb 14, 2018 PForm 4 → | Apr 2, 5:26 pm EDT | Veroni Brands Corp.no symbol | Tomasz Kotas10% Owner | 76,266 | $0.75 | $57,200 | 12,676,266 | +0.61% | plan? late |
| Jan 10, 2017 PForm 5 → | Apr 2, 2018, 4:01 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 1,127,217 | $0.0474 | $53,442 | 12,949,027 | +9.54% | plan? |
| Mar 27, 2017 PForm 5 → | Apr 2, 2018, 5:10 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 856,000 | $0.0433 | $37,084 | 12,949,027 | +7.08% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 3, 3:37 pm EDT | CCUR Holdings, Inc.CCUR | Julian D. Singer10% Owner | 7,300 | $4.75 | $34,674 | 2,672,768 | +0.27% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 4:43 pm EDT | INSIGNIA SYSTEMS INC/MNISIG | AIR T INC10% Owner | 19,000 | $1.61 | $30,666 | 3,360,816 | +0.57% | plan? |
| Apr 18, 2017 PForm 5 → | Apr 2, 2018, 5:58 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 411,000 | $0.0642 | $26,380 | 12,949,027 | +3.28% | plan? |
| Mar 30, 2018 PForm 4 → | Apr 3, 1:23 pm EDT | Chanticleer Holdings, Inc.HOTR | Michael D PruittCEO, Chairman, Director | 6,757 | $3.70 | $25,001 | 10,262 | +193% | plan? |
| Jun 13, 2016 PForm 5 → | Apr 2, 2018, 6:53 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 474,251 | $0.0501 | $23,759 | 12,949,027 | +3.80% | plan? |
| Aug 7, 2017 PForm 5 → | Apr 2, 2018, 7:36 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 495,618 | $0.0397 | $19,688 | 12,949,027 | +3.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 3, 7:59 am EDT | LADENBURG THALMANN FINANCIAL SERVICES INC.LTS | Mark ZeitchickExecutive Vice President, Director | 5,000 | $3.12 | $15,600 | 820,698 | +0.61% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 3, 8:02 am EDT | LADENBURG THALMANN FINANCIAL SERVICES INC.LTS | Richard M KrasnoDirector | 5,000 | $3.10 | $15,513 | 55,000 | +10.0% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 3, 7:55 am EDT | LADENBURG THALMANN FINANCIAL SERVICES INC.LTS | Richard LampenPresident and CEO, Director | 5,000 | $3.09 | $15,473 | 2,305,059 | +0.22% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 4:25 pm EDT | UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.UNIR | Howard R CurdCEO & Co-Chairman, Director, 10% Owner | 6,892 | $1.83 | $12,643 | 8,122,700 | +0.08% | plan? |
| Sep 14, 2017 PForm 5 → | Apr 2, 2018, 8:32 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 476,000 | $0.0253 | $12,056 | 12,949,027 | +3.82% | plan? |
| Apr 3, 2018 PForm 4 → | Apr 3, 8:17 am EDT | IGS Capital Group LtdIGSC | Seng Yeap KokCEO, CFO and Secretary, Director, 10% Owner | 32,000,000 | $0.0003 | $9,600 | 35,771,066 | +849% | plan? |
| Apr 3, 2018 PForm 4 → | Apr 3, 8:18 am EDT | IGS Capital Group LtdIGSC | Pontoon Boat Inc.10% Owner | 32,000,000 | $0.0003 | $9,600 | 35,771,066 | +849% | plan? |
| Mar 28, 2018 PForm 4 → | Apr 2, 4:36 pm EDT | Petro River Oil Corp.PTRC | Scot CohenEXECUTIVE CHAIRMAN, Director | 10,000 | $0.88 | $8,800 | 1,888,005 | +0.53% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 5:18 pm EDT | BioSig Technologies, Inc.BSGM | Steve ChaussyChief Financial Officer | 5,000 | $1.60 | $7,998 | 907,323 | +0.55% | plan? |
| Dec 1, 2017 PForm 5 → | Apr 2, 2018, 9:08 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 300,000 | $0.0163 | $4,883 | 12,949,027 | +2.37% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 2, 4:59 pm EDT | REGI U S INCRGUS | Paul Willard ChuteCEO, Director | 12,500 | $0.12 | $1,500 | 2,161,632 | +0.58% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.